Renata (DHA:RENATA) FFO


DHA:RENATA Renata PLC DHA:RENATA
83 GF Score
Price BDT451.30
GF Value BDT806.73
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Renata FFO?

FFO (Funds from operations) only applies to REITs.

DHA:RENATA
83GF Score
Renata PLC DHA:RENATA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Renata (DHA:RENATA) Overvalued in 2026?

Based on GuruFocus' analysis, Renata stock appears to be undervalued. The current stock price of BDT451.30 is trading 44.1% below its estimated GF Value™ of BDT806.73. GuruFocus considers Renata to be Significantly Undervalued.

Key valuation signals for DHA:RENATA:

  • FFO:
  • GF Value™: BDT806.73 vs. price of BDT451.30 (44.1% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the DHA:RENATA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renata Business Description

Address Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
83GF Score

Get the complete analysis for DHA:RENATA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT451.30
Price
BDT806.73
GF Value